Analysis of datasets from MASLD-HCC patients and from MASLD patients with high HCC risk revealed a significant positive correlation between FABP4 and either ITGB1 or CTNNB1, supporting ITGB1’s role in adipocyte-derived FABP4-driven MASLD-HCC. This evidence concerns the gene FABP4 and hepatocellular carcinoma.